|
Volumn 204, Issue 3, 2002, Pages 214-221
|
Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis
i
LEO Pharma Inc
(Canada)
|
Author keywords
Calcium; Psoriasis; Tar; Vitamin D
|
Indexed keywords
ALBUMIN;
ALKALINE PHOSPHATASE;
CALCIFEDIOL;
CALCIPOTRIOL;
CALCITRIOL;
CALCIUM;
CREATININE;
DITHRANOL;
OSTEOCALCIN;
PARATHYROID HORMONE;
PHOSPHATE;
PYRIDINOLINE;
TAR;
ARTICLE;
BONE TURNOVER;
CALCIUM METABOLISM;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MECHANISM;
DRUG MEGADOSE;
DRUG SAFETY;
FEMALE;
HORMONE BLOOD LEVEL;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MINERAL BLOOD LEVEL;
MULTICENTER STUDY;
OINTMENT;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PSORIASIS;
RANDOMIZED CONTROLLED TRIAL;
SCALP;
TIME;
TREATMENT OUTCOME;
URINARY EXCRETION;
VITAMIN BLOOD LEVEL;
ADMINISTRATION, TOPICAL;
ADULT;
AGED;
ANALYSIS OF VARIANCE;
ANTHRALIN;
CALCITRIOL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
OINTMENTS;
PROBABILITY;
PSORIASIS;
SEVERITY OF ILLNESS INDEX;
SOLUTIONS;
TREATMENT OUTCOME;
|
EID: 18444386181
PISSN: 10188665
EISSN: None
Source Type: Journal
DOI: 10.1159/000057884 Document Type: Article |
Times cited : (26)
|
References (23)
|